Aim: The purpose of this research work was to develop a bilayer tablet of antihypertensive drugs having sustained release (SR) layer of propranolol hydrochloride and immediate release (IR) layer of ramipril. Objectives: In the present investigation, an attempt was made to reduce the frequency, units of dose administration, and to improve the patient compliance. Materials and Methods: The tablets were prepared using ethyl cellulose and hydroxypropyl methylcellulose K-15M for sustained layer of propranolol hydrochloride and superdisintegrants crospovidone and sodium starch glycolate for IR layer of ramipril. Preformulation studies of propranolol hydrochloride and ramipril like compatibility studies with polymers using Fourier-transform IR were carried out. The drugs and excipients were found to be compatible with each other. Compressed tablets were evaluated for hardness, thickness, weight variation, friability, drug content, in vitro drug release studies, and stability studies Results and Discussion: Nine batches of bilayer tablets of propranolol hydrochloride and ramipril were developed using wet granulation and direct compression techniques, respectively. Among the nine formulations, F9 batch showed best drug release over 12 h and subjected to stability studies for 2 months. Conclusion: The optimized F9 formulation for IR showed a release of 99.27% and propranolol hydrochloride has an in vitro release of 99.39%. Therefore, bilayer ramipril IR and SR tablets of propranolol hydrochloride can be used to improve the management of hypertension.
INTRODUCTION
T he oral route of drug administration is the most convenient and commonly used method of drug delivery. [1] Recently, combined therapy with drugs of same therapeutic effects or different therapeutic effects shows an effective way in the treatment of diseases. To optimize their effects, different drugs should be used at their optimal dose and different periods in the treatment. One of the main challenges of combined therapy is to control the release behavior of each drug independently. On the basis of these considerations, we have proposed a new oral delivery device, in the form of antihypertensive bilayer tablets, that is IR layer of ramipril as the first layer and the second layer is SR layer of propranolol hydrochloride. [2] Ramipril is an ACE inhibitor and propranolol hydrochloride is a beta-blocker they are used to the treatment of hypertension. Hypertension is the most common cardiovascular disease; its prevalence increases with increasing age. A combination of ACE inhibitors and beta-blockers helps for the improvement in cardiac function after myocardial infarction. This combination does not have any pharmacokinetic interactions. Bilayer tablets formulated as IR layer of ramipril to obtain a prompt release of drug with the aim of reaching a high serum concentration in a short period of time. The second layer is SR layer of propranolol hydrochloride is a prolonged release hydrophilic matrix, which is designed to maintain an effective plasma level for a prolonged period time, to avoid repeated administrations. [3, 4] Bilayer tablets are formulated for decreasing the dosing frequency, separate two RESEARCH ARTICLE as sustained layer incompatible substances, and gradual release of two drugs in a single dosage form. [5, 6] 
MATERIALS AND METHODS
Ramipril and propranolol hydrochloride gifted from Hetero. Ethyl cellulose, hydroxypropyl methylcellulose (HPMC) K-15M, crospovidone, sodium starch glycolate, microcrystalline cellulose, magnesium stearate, talc, hydrochloric acid, sodium hydroxide, and methanol purchased from Finar Chemicals. Lactose monohydrate and lactose spray dried gifted by Merck.
Experimental work

Preformulation studies
FTIR absorption spectra of pure drug and all polymers used like and the combination of drugs and polymers were shown no significant interaction between drug and polymers. The graphs obtained were shown in Figure 1 
Preparation of bilayer tablets
Bilayer tablets prepared by two steps, IR layer of ramipril was prepared by direct compression method using crospovidone and sodium starch glycolate as superdisintegrants in various concentrations and the SR layer of propranolol hydrochloride was prepared by wet granulation method using ethyl cellulose and HPMC K-15M in different concentrations as the drug release-retarding polymers.
Manufacturing process of the immediate release (IR) layer of ramipril
The procedure for the preparation was direct compression. All ingredients were mixed, except magnesium stearate, and talc. Finally, dye was added together with magnesium stearate and talc, later, the powder mixture was punched with 12 mm size punch.
Manufacturing process of the sustained release (SR) granules of propranolol hydrochloride
Wet granulation method was followed, all the ingredients were mixed, except magnesium stearate and talc with water and a wet mass was formed. The formed mass was passed through mesh 10# and the formed granules were dried and then passed through mesh 24# and punched with 12 mm size punch [ Table 1 ].
Evaluations
Characterization of granules
Bulk density, tapped density, Hausner's ratio, Carr's index, and angle of repose. [7] Evaluation of bilayer tablets Thickness, hardness, friability, disintegration time, weight variation test, drug content, in vitro release study, and stability study as per ICH guidelines [ Table 2 ]. [8, 9] Talc  3  3  3  3  3  3  3  3  3   Lactose spray dride  265  225  185  145  105  285  265  245  225   Total SR layer weight  400  400  400  400  400  400  400  400  400 Total bilayer tablet weight 500 500 500 500 500 500 500 500 500 All values expressed as mean±SD (n=3) as sustained layer
Assay method was performed for the tablets and was shown in Table 3 .
RESULTS AND DISCUSSION
In vitro dissolution studies
The in vitro drug release test was carried out using the USP type-II apparatus (paddle). The dissolution medium is 900 mL of 0.1 N HCl for the first 2 h and lateral 10 h with 6.8 pH phosphate buffer. The paddle was rotated at 75 rpm at the temperature (37°C ± 0.5°C). The sampling was carried out at regular intervals and was replaced by means after each sampling interval. The sampling was done at regular intervals and was replaced by media after each sampling interval. The samples are then analyzed spectrophotometrically at λ max of the drug. [10, 11] The in vitro dissolution studies were tabulated in Tables 4-6. 
CONCLUSION
Nine formulations of the ramipril and propranolol hydrochloride bilayer tablets were prepared using direct compression and wet granulation technique. The physical drug and excipients compatibility studies using FT-IR were conducted the studies revealed that there was no interaction between ramipril, propranolol hydrochloride, and excipients used in the preparation of bilayer tablet. The IR layer of ramipril was prepared using with different superdisintegrants such as crospovidone and sodium starch glycolate with different ratios. The sustained layer of propranolol hydrochloride was prepared by wet granulation technique using ethyl cellulose and HPMCS K-15M as polymers with different ratios. The prepared nine batches of bilayer tablets were evaluated for hardness, thickness, weight variation, friability, drug content, in vitro drug release studies, and stability studies. The formulation F9 was showed best drug release among all nine formulations. Finally, it concludes that F9 formulation shows the best drug release in both the layers (ramipril and propranolol hydrochloride). The drug release of propranolol hydrochloride is 99.39% and 99.27% for ramipril. Stability studies were performed for optimized formulation. The tablets were observed for accelerated stability studies for 2 months; the obtained results were within specifications. 
